Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study.
Cao Y, Wang M, Wang F, Guo W, Ma Y, Li X, He Y, Pang A, Zhang R, Zhai W, Chen X, Ma Q, Wei J, Yang D, Huang Y, Feng D, Liu J, Gao X, Wen S, Wang W, Wang T, Li Y, Fang X, Li Y, Zhang X, Cai Y, Wang Y, Cao W, Lu R, Feng S, Guo R, Fu Y, Du X, Liu Z, Wang X, Wang L, Ma L, Liu C, Zhang X, Han M, Jiang E.
Cao Y, et al. Among authors: liu j, liu z, liu c.
Chin Med J (Engl). 2024 May 5;137(9):1115-1117. doi: 10.1097/CM9.0000000000002963. Epub 2024 Feb 2.
Chin Med J (Engl). 2024.
PMID: 38310445
Free PMC article.
No abstract available.